Methodist Health
Rated 2009 Top 100 Integrated Healthcare Networks
Home About Us Careers Locations Healthcare Services Your Health Patients & Visitors For Healthcare Professionals
Diagnostic Services
Medical Services
Cancer Services
Cardiac Services
Emergency Services
Extended Care Services
Gastroenterology Services
Home Care Services
Hospice Services
Minor Medical Centers
Neuroscience Institute
Orthopaedic Services
Palliative Care Services
Rehabilitation Services
Sleep Disorders Center
Transplant Institute
Women's Services
Work Injury Care
Additional Services
Employee Assistance Program
Surgical Services
Home  » Healthcare Services  » Medical Services  » Neuroscience Institute  » Research  » Clinical Trials

Clinical Trials

Clinical trials are organized studies that are designed to determine the safety and effectiveness of a new treatment. The most promising agents and therapies are selected for inclusion in the treatment studies at the Methodist Neuroscience Institute.

For current Clinical Trials, please contact:
Rexann G. Pickering, Ph.D., R.N.
Administrator, Human Protection
MHIRB Administration
1325 Eastmoreland Ave., Suite 574
Memphis, Tennessee 38104
Phone: 901.516.2323
Fax: 901.516-2456

2008-034 
  BIBW 2992 with or without daily temozolomide in the treatment of patients with recurrent malignant glioma
2008-038 
  Cilengitide for subjects with newly diagnosed glioblastoma multiforme and methylated MGMT gene promoter – a multicenter, open-label, controlled phase III study, testing cilengitide in combination with standard treatment (temozolomide with concomitant radiation therapy, followed by temozolomide maintenance therapy) versus standard treatment alone (CENTRIC).
Contact Us Web Site Privacy Practices Patient Privacy Practices Disclaimer Newsroom
  Methodist Healthcare is an integrated health care delivery system, dedicated to the art of healing through our faith-based commitment to minister to the whole person. 1211 Union Avenue, Memphis, Tennessee 38104 • (901) 516-7000